Susanna B. Park

Prince of Wales Clinical School, University of New South Wales

Affiliated withUniversity of New South Wales

Research Area

Biography

Susanna B. Park has not added Biography.
If you are Susanna B. Park and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 28	2012

Other Publications

Article	Year
Heterogeneity of phasic cholinergic signaling in neocortical neurons. Journal of neurophysiology\| PubMed ID: 17122323	2007
Assessment of nerve excitability in toxic and metabolic neuropathies. Journal of the peripheral nervous system : JPNS\| PubMed ID: 18346228	2008
Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 19164207	2009
Axonal ion channels from bench to bedside: a translational neuroscience perspective. Progress in neurobiology\| PubMed ID: 19699774	2009
Oxaliplatin-induced neurotoxicity: changes in axonal excitability precede development of neuropathy. Brain : a journal of neurology\| PubMed ID: 19745023	2009
Oxaliplatin-induced lhermitte's phenomenon as a manifestation of severe generalized neurotoxicity. Oncology\| PubMed ID: 20016227	2009
Regional differences in ulnar nerve excitability may predispose to the development of entrapment neuropathy. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology\| PubMed ID: 20591727	2011
Acute, reversible axonal energy failure during stroke-like episodes in MELAS. Pediatrics\| PubMed ID: 20679297	2010
Utilizing natural activity to dissect the pathophysiology of acute oxaliplatin-induced neuropathy. Experimental neurology\| PubMed ID: 20965170	2011
Early, progressive, and sustained dysfunction of sensory axons underlies paclitaxel-induced neuropathy. Muscle & nerve\| PubMed ID: 21321953	2011
The contribution of SK3 polymorphisms to acute oxaliplatin-induced neurotoxicity: direct or indirect effects? Cancer chemotherapy and pharmacology\| PubMed ID: 21327679	2011
Long-term neuropathy after oxaliplatin treatment: challenging the dictum of reversibility. The oncologist\| PubMed ID: 21478275	2011
Dose effects of oxaliplatin on persistent and transient Na+ conductances and the development of neurotoxicity. PloS one\| PubMed ID: 21494615	2011
Neuroprotection for oxaliplatin-induced neurotoxicity: what happened to objective assessment? Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 21606425	2011
Modulatory effects on axonal function after intravenous immunoglobulin therapy in chronic inflammatory demyelinating polyneuropathy. Archives of neurology\| PubMed ID: 21747028	2011
Purple pigments: the pathophysiology of acute porphyric neuropathy. Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology\| PubMed ID: 21855406	2011
Dysfunction of axonal membrane conductances in adolescents and young adults with spinal muscular atrophy. Brain : a journal of neurology\| PubMed ID: 21926101	2011
Activity-dependent conduction failure: molecular insights. Journal of the peripheral nervous system : JPNS\| PubMed ID: 22003929	2011
Longitudinal assessment of oxaliplatin-induced neuropathy. Neurology\| PubMed ID: 22232054	2012
Impact of oxaliplatin-induced neuropathy: a patient perspective. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer\| PubMed ID: 22426503	2012
Progressive Axonal Dysfunction Precedes Development of Neuropathy in Type 2 Diabetes. Diabetes\| PubMed ID: 22522615	2012